Impact

Home
Impact
img-5
Our Guiding Principles

Our Commitment

At PEAL, responsible investing means more than financial returns. By focusing on longevity and hormone health, we back businesses that measurably improve people’s lives, and we hold them to rigorous governance and close alignment between management, investors and patients.

Across Fund I, that principle takes the form of a single integrated platform. Combining accredited medical training, consumer education, clinical services and hormone supply lets us scale efficiently in the UK and internationally, sell across our own divisions and build a business positioned for a strong exit. 

 

img-5
Social Impact

Improving Lives Through Healthcare

We invest in longevity and hormone health businesses across five connected divisions: Consumer Education, Medical Education, Clinics, Research & Data and Hormone Supply.

Each division feeds the next. A woman who downloads Balance can be treated by a clinician trained through our education businesses, whether in one of our own clinics or in the clinician’s own practice, and the evidence from her treatment feeds our research and the products we develop. Because we are present at every stage of that journey, each patient or clinician we reach creates opportunities across the rest of the platform.

N
Consumer education helping 1.6m women understand their symptoms and seek care
N
Accredited training that has given 91,000+ clinicians the skills to treat them
N
Clinics providing specialist diagnosis and treatment to more than 100,000 women
N
Hormone supply that puts effective treatment within reach of every woman
N
The world’s most published peer-reviewed research on hormone health, improving care for women everywhere

Responsible Investment, Global Impact

Responsible investment, for us, starts with what we invest in. We back businesses that improve women’s health, an area of medicine underserved for decades. We hold the L&H Platform to high standards of governance and inclusive leadership, from diligence through to exit, and we measure progress rather than assume it.

U

Governance & Accountability

We take controlling or influential positions and hold board seats across the L&H Platform, so governance decisions are made with us in the room. Where a business needs it, we step in through interim roles or executive support to lead restructuring or repositioning.

    • Board alignment on value creation across all five divisions
    • Transparent reporting and KPIs from every portfolio business
    • Strategic governance and exit planning
    • Hands-on operational involvement with clear accountability

Diversity, Equity & Inclusion

Women’s hormone health is chronically underserved: fewer than 5% of eligible women in the US are treated for menopause. The L&H Platform exists to close that gap, and we favour businesses that:

  • Widen access to evidence-based hormone care for every patient group
  • Train clinicians in inclusive practice, through more than 91,000 professionals and counting
  • Treat underserved groups, from women in menopause to men in andropause

Environmental Responsibility

We recognise the footprint of clinical operations, hormone supply and diagnostics. The platform is not emissions-intensive, but we track and work to reduce environmental impact across every division.

    • Energy use and supplier emissions across clinics and education
    • Waste management in clinical and laboratory settings
    • Lower-impact packaging and logistics for hormone products